✦ LIBER ✦

Donor lymphocyte infusions can result in sustained remissions in patients with residual or relapsed lymphoid malignancy following allogeneic haemopoietic stem cell transplantation

✍ Scribed by Russell, N H; Byrne, J L; Faulkner, R D; Gilyead, M; Das-Gupta, E P; Haynes, A P

Book ID: 110014709
Publisher: Nature Publishing Group
Year: 2005
Tongue: English
Weight: 124 KB
Volume: 36
Category: Article
ISSN: 0007-1188
DOI: 10.1038/sj.bmt.1705074

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Booster Infusion of T-Cell Depleted, CD3

Booster Infusion of T-Cell Depleted, CD34+ Enriched, Donor Cells Results in Sustained Count Recovery for Patients with Poor Graft Function Following Allogeneic Stem Cell Transplantation

✍ G. Ramsingh; M. Rettig; J. Gabriel; P. Westervelt; G.L. Uy; C.N. Abboud; J.F. Di 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 50 KB

The value of monitoring minimal residual

The value of monitoring minimal residual disease in the patients with donor lymphocyte infusion as intervention of relapsed/refractory acute lymphoblastic leukemia after allogeneic hematopoietic stem cell transplantation

✍ Xiao Ma; Depei Wu; Aining Sun; Huiying Qiu; Zhenzhen Fu; Xiaojin Wu; Suning Chen 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 389 KB 👁 2 views

Minimal GVHD following in-vitro Tcell–de

Minimal GVHD following in-vitro Tcell–depleted allogeneic stem cell transplantation with reduced-intensity conditioning allowing subsequent infusions of donor lymphocytes in patients with hematological malignancies and solid tumors

✍ Renée M.Y Barge; Susanne Osanto; W.A.F.Erik Marijt; C.W.J.Ingrid Starrenburg; Wi 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 130 KB

Donor lymphocyte infusion followed by in

Donor lymphocyte infusion followed by interferon-α plus low dose cyclosporine A for modulation of donor CD3 cells activity with monitoring of minimal residual disease and cellular chimerism in a patient with first hematologic relapse of chronic myelogenous leukemia after allogeneic bone marrow transplantation

✍ Michal Leda; Dariusz Ladon; Anna Pieczonka; Dariusz Boruczkowski; Justyna Jólkow 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 136 KB

Combining Azacitidine (Vidaza®, Aza) and

Combining Azacitidine (Vidaza®, Aza) and Donor Lymphocyte Infusions (DLI) as First Salvage Treatment in Patients (PTS) With Acute Myeloid Leukemia (AML) or Myelodysplastic Syndromes (MDS) Relapsing After Allogeneic Hematopoietic Stem Cell Transplantation (allo-SCT): Interim-Analysis From the Azarela-Trial (NCT-00795548)

✍ T. Schroeder; A.G. Czibere; N. Kröger; U. Platzbecker; G. Bug; L. Uharek; T. Luf 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 63 KB